Pure Global
NCT04479826

Unannounced Meal Handling of Advanced Closed Loop Insulin Delivery in Monitored Condition

Sheba Medical Center·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
type1diabetes
Drug/Device/Intervention
Advanced hybrid closed loop system
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Sheba Medical Center
Location
Tel-Hashomer, Israel
Timeline & enrollment
Phase
N/A
Start date
Jul 16, 2020
End date
Jul 01, 2021
Enrollment
16 participants
Primary outcome

Time in ranges

Summary

The study will follow participants for the periods of 3 months while using an advanced hybrid
 closed loop algorithm in free living conditions . Each period will have a different meal
 handling protocols. The objective is to identify the mitigation of the algorithm with
 different meal handling approaches.

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04479826
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT04479826 through Pure Global AI's free database. This phase not specified trial is sponsored by Sheba Medical Center and is currently Recruiting. The study focuses on type1diabetes. Target enrollment is 16 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.